Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease in sensitivity of D-dimer for acute venous thromboembolism after starting anticoagulant therapy.

F Couturaud1, C Kearon, S M Bates

  • 1Hamilton Civic Hospitals Research Centre, and McMaster University, Hamilton, Ontario, Canada.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|April 11, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra Study.

Thrombosis research·2026
Same author

[Imaging tests for the diagnosis of dyspnea during pregnancy].

Revue des maladies respiratoires·2025
Same author

Physicochemical and functional assessment of messenger RNA 5'Cap-end impurities under forced degradation conditions.

Molecular therapy. Nucleic acids·2025
Same author

[Translation into French and republication of: "Recurrent venous thromboembolism in anticoagulated cancer patients: diagnosis and treatment"].

La Revue de medecine interne·2024
Same author

[Translation into French and republication of: "Management of cancer-associated thromboembolism in vulnerable population"].

La Revue de medecine interne·2024
Same author

[Translation into French and republication of: "Anticoagulant treatment of cancer-associated thromboembolism"].

La Revue de medecine interne·2024
Same journal

Pampiniform venous plexus thrombosis in a 37 years-old male patient with severe thrombocytosis: a multifactorial aetiology.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

PROS1 Cys475Tyr mutation associated with a type III protein S deficiency pattern.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

Dynamic microclot profiling: thromboelastography advances precision management in long COVID and myalgic encephalomyelitis/chronic fatigue syndrome.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

Genetic characterization of Glanzmann thrombasthenia: insights from novel igta2b mutations in a Tunisian patient cohort.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

Uterine fibroids as an underrecognized risk factor for venous thromboembolism: a narrative review.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

SEER sonorheometry enhances fibrinolysis detection during liver transplantation with heparin.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
See all related articles

D-dimer levels decrease significantly within 24 hours of starting heparin therapy for acute venous thromboembolism (VTE). This reduction impacts the test

Area of Science:

  • Medical Diagnostics
  • Hematology
  • Thrombosis Research

Background:

  • D-dimer testing is a key diagnostic tool for excluding acute venous thromboembolism (VTE).
  • Anticoagulant therapy is known to lower D-dimer levels in thrombosis patients.
  • This raises concerns about the reliability of D-dimer testing after initiating anticoagulant treatment.

Purpose of the Study:

  • To quantify the decrease in D-dimer levels within 24 hours of initiating heparin therapy for acute VTE.
  • To assess the impact of this D-dimer reduction on the diagnostic sensitivity of VTE exclusion.
  • To evaluate the clinical implications for D-dimer testing in patients already on anticoagulant therapy.

Main Methods:

  • A literature review was conducted to determine the typical percentage decrease in D-dimer levels 24 hours after starting heparin in acute VTE patients.

Related Experiment Videos

  • Data from a prospective study on patients with confirmed deep vein thrombosis and/or pulmonary embolism were used as baselines.
  • The calculated D-dimer decrease was applied to existing study results to estimate the resulting change in diagnostic sensitivity and specificity.

    • Main Results:

    • The literature review indicated a mean D-dimer level decrease of 25% within 24 hours of heparin initiation in acute VTE patients.
    • Applying this 25% reduction to a recent study's data showed a drop in sensitivity from 95.6% to 89.4%.
    • Confidence intervals for sensitivity also narrowed, indicating a less precise diagnostic measure post-heparin initiation.

    Conclusions:

    • D-dimer levels demonstrably decrease within 24 hours of commencing heparin therapy for acute VTE.
    • This reduction in D-dimer levels leads to a clinically significant decrease in the test's sensitivity for VTE exclusion.
    • The findings suggest that D-dimer testing may be less reliable for excluding VTE in patients who have already started anticoagulant therapy.